Cargando…

SERCA2a stimulation by istaroxime improves intracellular Ca(2+) handling and diastolic dysfunction in a model of diabetic cardiomyopathy

AIMS : Diabetic cardiomyopathy is a multifactorial disease characterized by an early onset of diastolic dysfunction (DD) that precedes the development of systolic impairment. Mechanisms that can restore cardiac relaxation improving intracellular Ca(2+) dynamics represent a promising therapeutic appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torre, Eleonora, Arici, Martina, Lodrini, Alessandra Maria, Ferrandi, Mara, Barassi, Paolo, Hsu, Shih-Che, Chang, Gwo-Jyh, Boz, Elisabetta, Sala, Emanuela, Vagni, Sara, Altomare, Claudia, Mostacciuolo, Gaspare, Bussadori, Claudio, Ferrari, Patrizia, Bianchi, Giuseppe, Rocchetti, Marcella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930067/ https://www.ncbi.nlm.nih.gov/pubmed/33792692 http://dx.doi.org/10.1093/cvr/cvab123

Ejemplares similares

Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
por: Luraghi, Andrea, et al.
Publicado: (2022)

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
por: Altomare, Claudia, et al.
Publicado: (2021)

Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging
por: Lazzarini, Edoardo, et al.
Publicado: (2022)

Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
por: Lodrini, Alessandra Maria, et al.
Publicado: (2020)

Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime
por: Racioppi, María Florencia, et al.
Publicado: (2021)

Istaroxime: A rising star in acute heart failure
por: Aditya, Suruchi, et al.
Publicado: (2012)

Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022)

Cardiac Plin5 interacts with SERCA2 and promotes calcium handling and cardiomyocyte contractility
por: Cinato, Mathieu, et al.
Publicado: (2023)

Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy
por: Kamel, S. M., et al.
Publicado: (2021)

Safety and Efficacy of Istaroxime in Patients With Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
por: Khalid Khan, Saad, et al.
Publicado: (2023)

Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
por: Røe, Åsmund T, et al.
Publicado: (2019)

Importance of SERCA2a on early isolated diastolic dysfunction induced by supravalvular aortic stenosis in rats
por: Silveira, C.F.S.M.P., et al.
Publicado: (2017)

Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium
por: Wallner, Markus, et al.
Publicado: (2017)

Carbonylation Contributes to SERCA2a Activity Loss and Diastolic Dysfunction in a Rat Model of Type 1 Diabetes
por: Shao, Chun Hong, et al.
Publicado: (2011)

Contractile Behavior of Mouse Aorta Depends on SERCA2 Isoform Distribution: Effects of Replacing SERCA2a by SERCA2b
por: Fransen, Paul, et al.
Publicado: (2020)

Evaluation of the Anticancer and Biological Activities of Istaroxime via Ex Vivo Analyses, Molecular Docking and Conceptual Density Functional Theory Computations
por: Gok, Ege, et al.
Publicado: (2023)

Altered functional differentiation of mesoangioblasts in a genetic myopathy
por: Altomare, Claudia, et al.
Publicado: (2013)

Low Density Lipoproteins Promote Unstable Calcium Handling Accompanied by Reduced SERCA2 and Connexin-40 Expression in Cardiomyocytes
por: Barriga, Montserrat, et al.
Publicado: (2013)

Balanced changes in Ca buffering by SERCA and troponin contribute to Ca handling during β-adrenergic stimulation in cardiac myocytes
por: Briston, Sarah J., et al.
Publicado: (2014)

A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes
por: Altomare, Claudia, et al.
Publicado: (2023)

Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes
por: Lazzarini, Edoardo, et al.
Publicado: (2022)

Altered SERCA Expression in Breast Cancer
por: Christodoulou, Panayiota, et al.
Publicado: (2021)

Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
por: Dhondup, Yangchen, et al.
Publicado: (2015)

Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca(2+) Handling and Arrhythmogenesis
por: Vafiadaki, Elizabeth, et al.
Publicado: (2022)

Differential Modulation of SERCA2 Isoforms by Calreticulin
por: John, Linu M., et al.
Publicado: (1998)

SERCA is critical to control the Bowditch effect in the heart
por: Balcazar, Darío, et al.
Publicado: (2018)

Targeting oncogenic Notch signaling with SERCA inhibitors
por: Pagliaro, Luca, et al.
Publicado: (2021)

SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin‐deficient mice
por: Braun, Jessica L., et al.
Publicado: (2019)

Functional characterization and anti-cancer action of the clinical phase II cardiac Na(+)/K(+) ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor
por: Alevizopoulos, Konstantinos, et al.
Publicado: (2016)

Atomic-Level Characterization of the Activation Mechanism of SERCA by Calcium
por: Espinoza-Fonseca, L. Michel, et al.
Publicado: (2011)

Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins
por: Cardi, Delphine, et al.
Publicado: (2010)

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC)
por: Metra, Marco, et al.
Publicado: (2022)

Candesartan Cilexetil Attenuates Arrhythmogenicity Following Pressure Overload in Rats via the Modulation of Cardiac Electrical and Structural Remodeling and Calcium Handling Dysfunction
por: Chang, Gwo‐Jyh, et al.
Publicado: (2022)

The Evolutionary History of Sarco(endo)plasmic Calcium ATPase (SERCA)
por: Altshuler, Ianina, et al.
Publicado: (2012)

SPEG, an Indispensable Kinase of SERCA2a for Calcium Homeostasis
por: Kusumoto, Dai, et al.
Publicado: (2019)

Exploring Impaired SERCA Pump-Caused Alternation Occurrence in Ischemia
por: Liu, Jiaqi, et al.
Publicado: (2019)

Measuring SERCA-mediated calcium uptake in mouse muscle homogenates
por: Geromella, Mia S., et al.
Publicado: (2023)

Role of SERCA3 in the Prognosis and Immune Function in Pan-Cancer
por: Li, Jiajia, et al.
Publicado: (2022)

Polyarginine Cell-Penetrating Peptides Bind and Inhibit SERCA2
por: Lunde, Per Kristian, et al.
Publicado: (2023)

CD44 regulates Epac1-mediated β-adrenergic-receptor-induced Ca(2+)-handling abnormalities: implication in cardiac arrhythmias
por: Chan, Yi-Hsin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4cooc03864hehnk5ormg7pp7hf